Patient
SITE007-0231
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE007 (JPN) (Dr. Dubois)
consented 2026-05-25
Adverse events
6
Serious AEs
1
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 6
Grade 1 Fatigue — outcome: RECOVERED/RESOLVED; onset 2023-03-13 (study day 96); relationship: not assessed
Grade 1 Hypothyroidism — outcome: RECOVERED/RESOLVED; onset 2023-03-13 (study day 96); relationship: not assessed
Grade 3 Adrenal insufficiency — outcome: RECOVERED/RESOLVED; onset 2023-03-02 (study day 85); relationship: not assessed; serious criteria: hospitalization
Grade 2 Alopecia — outcome: RECOVERED/RESOLVED; onset 2023-02-17 (study day 72); relationship: NOT RELATED
Grade 1 Rash — outcome: RECOVERED/RESOLVED; onset 2023-02-02 (study day 57); relationship: not assessed
Grade 1 Anaemia — outcome: RECOVERED/RESOLVED; onset 2023-01-26 (study day 50); relationship: NOT RELATED
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.